Continental Advisors’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
Other funds holding AVNS
PIM
SCM
PAM
Continental Advisors's AVNS Position: Q1 2017 in Review
Continental Advisors sold out of Avanos Medical (AVNS) in Q1 2017, closing a stake of 42,700 shares — an estimated $1.58M sold.
Continental Advisors first reported a position in AVNS in Q3 2015 and held it in 6 quarters. The position peaked at $1.66M in Q4 2015. 335 funds tracked by Wall St. Rank hold AVNS as of Q1 2017.
- Continental Advisors reported no remaining Avanos Medical position as of Q1 2017 after selling out during the quarter.
- Continental Advisors sold 42,700 Avanos Medical shares in Q1 2017, an estimated $1.58M.
- Continental Advisors first reported a position in Avanos Medical in Q3 2015 and held it in 6 quarters.
- Continental Advisors's Avanos Medical position peaked at $1.66M in Q4 2015.
- 335 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2017.
Based on Continental Advisors's 13F filing for Q1 2017, filed 15 May 2017.